All In MedTech

Company

Penumbra

Funding, FDA decisions, device trials, adverse event reports and recalls filed under this company's name in public data. Records are matched by name, so a subsidiary or an unusual spelling can be missed.

Last checked: Nov 20, 2026Source: SEC EDGAR, openFDA and ClinicalTrials.govMethods & limitations

Penumbra is on our public-company list (ticker PEN). Naming a company here is not a recommendation of it or of any security.

Financing

Public company. Figures from its SEC financial statements, plus private placements it reported on Form D.

Public

Listed

PEN

NYSE · Penumbra Inc

Public float

$9.70B

Value of shares held by non-insiders on Jun 30, 2025

Revenue

$1.40B

Fiscal year ending Dec 31, 2025

Net income

$178M

Fiscal year ending Dec 31, 2025

R&D spending

$89.8M

Fiscal year ending Dec 31, 2025

Cash

$254M

As of Sep 30, 2026

Long-term debt

Not reported

Shares outstanding

39.4M

As of Oct 14, 2026

Private placements (Form D)

One row per Form D offering, newest first. The amount raised is the latest amended figure. An offering can run for months and close in several tranches. Matched by company name, so check the filing.

First saleTypeRaisedRound sizeInvestorsExemption and agentFiling
Filed May 13, 2014Equity$0$70.0M0Rule 506(b)Agent: Perella Weinberg Partners LPForm D ↗May 13, 2014
Jan 1, 2012Equity$121K$121K3Rule 506Form D ↗Nov 1, 2012

Company details

From the company's latest Form D.

Legal name
Penumbra Inc
Headquarters
Alameda, California
Incorporated
Delaware over five years before filing
Entity type
Corporation
Revenue range
Decline to Disclose
Industry filed under
Other Health Care

Executives, directors and promoters

As listed on the latest Form D.

    7 more people on the filing with a free account

    Not in public filings: valuations, share prices and investors' names. Private databases such as PitchBook and Crunchbase estimate these from press releases and surveys. Not every round is filed: companies raising under other exemptions, or from foreign investors only, may not file Form D. Nothing here is investment advice.

    Investors

    5%+ shareholders from SEC Schedule 13D/13G filings since Dec 1, 2024, and SBIR/STTR grants (NIH through Nov 10, 2026, other agencies through 2023). Venture investors in private rounds are not in public filings.

    The investor database is part of the paid tier

    For Penumbra we have 1 shareholder with 5% or more.

    It is included for signed-in readers who have credit, along with the daily news digest. Credit is also what pays for AI device summaries.

    Latest FDA decisions

    The 8 newest of 68 since 2015.

    Search the Clearance Tracker

    65 more FDA decisions with a free account

    Device trials

    Trials on ClinicalTrials.gov that list this company as lead sponsor, most recently updated first.

    Open in the Trial Radar

    28 more trials with a free account

    Reports received

    449

    Received Nov 1, 2025 to Nov 20, 2026

    Malfunction reports

    388

    86% of reports

    Injury reports

    55

    12% of reports

    Death reports

    6

    1.3% of reports

    Adverse event reports received per month

    Reports that name this company as manufacturer, by the date FDA received them. The newest month is incomplete.

    Search the MAUDE Monitor
    • Malfunction
    • Injury
    • Death
    • Other
    View as table
    MonthMalfunctionInjuryDeathOther
    Dec 2339600
    Jan 2425760
    Feb 2421850
    Mar 24331720
    Apr 24421010
    May 2449400
    Jun 2419300
    Jul 2427420
    Aug 2434400
    Sep 2425500
    Oct 2428920
    Nov 2428400
    Dec 2430210
    Jan 2522610
    Feb 25301010
    Mar 2530300
    Apr 25331240
    May 2528820
    Jun 25351030
    Jul 2524200
    Aug 2530530
    Sep 2526800
    Oct 2534800
    Nov 2525410
    Dec 2536600
    Jan 2627700
    Feb 2621230
    Mar 26371200
    Apr 2649100
    May 2626100
    Jun 2639200
    Jul 2623400
    Aug 2636210
    Sep 2645810
    Oct 2624600
    Nov 260000

    Device types named most often

    Last 12 months, by FDA product code. A company that sells more gets more reports.

    6 more in this ranking with a free account

    Brand names named most often

    Last 12 months, as written on the reports. One product can appear under several spellings.

    7 more in this ranking with a free account

    Recent recalls

    From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.

    9 more recall records with a free account

    Back to all tools

    For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.